Organon Reports Results for the Third Quarter Ended September 30, 2021
Go back to Organon Reports Results for the Third Quarter Ended September 30, 2021| Merck & Co. (NYSE: MRK) | Delayed: 128.86 +2.08 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.78 | 52 Week High | $65.46 | |||
| Open | $128.77 | 52 Week Low | $47.97 | |||
| Day High | $129.69 | P/E | 87.66 | |||
| Day Low | $127.89 | EPS | $1.47 | |||
| Volume | 10,174,126 | |||||
| (NYSE: OGN) | Delayed: 13.51 -0.05 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.56 | 52 Week High | $8.00 | |||
| Open | $13.56 | 52 Week Low | $8.00 | |||
| Day High | $13.56 | P/E | N/A | |||
| Day Low | $13.49 | EPS | $0.00 | |||
| Volume | 2,894,912 | |||||
